Therapeutics and Targets: Pharmacology and Toxicology

Contributing journals to this collection:
Cancer Prevention Journals Portal, Cancer Prevention Journals Portal Content, , Cancer Reviews Online, Molecular Cancer Research, Cancer Prevention Research, Molecular Cancer Therapeutics, Cancer Research, Cancer Reviews Online Content, Clinical Cancer Research, and Cancer Epidemiology Biomarkers & Prevention

Citations 1-10 of 10 total displayed.

Most recent content

Reviews
Therapeutic Nanoparticles for Drug Delivery in Cancer

Kwangjae Cho, Xu Wang, Shuming Nie, Zhuo (Georgia) Chen, and Dong M. Shin
Clin. Cancer Res. 2008; 14: 1310-1316. [Abstract] [Full text] [PDF]  

Past content

Reviews
Medulloblastoma: From Molecular Pathology to Therapy

Alessandra Rossi, Valentina Caracciolo, Giuseppe Russo, Krzysztof Reiss, and Antonio Giordano
Clin. Cancer Res. 2008; 14: 971-976. [Abstract] [Full text] [PDF]  

Reviews
Can Inhibiting Dihydropyrimidine Dehydrogenase Limit Hand-Foot Syndrome Caused by Fluoropyrimidines?

Jane L. Yen-Revollo, Richard M. Goldberg, and Howard L. McLeod
Clin. Cancer Res. 2008; 14: 8-13. [Abstract] [Full text] [PDF]  

Reviews
Cardiac Toxicity in Breast Cancer Survivors: Review of Potential Cardiac Problems

Brian R.J. Healey Bird and Sandra M. Swain
Clin. Cancer Res. 2008; 14: 14-24. [Abstract] [Full text] [PDF]  

Reviews
The application of cassette dosing for pharmacokinetic screening in small-molecule cancer drug discovery

Nicola F. Smith, Florence I. Raynaud, and Paul Workman
Mol. Cancer Ther. 2007; 6: 428-440. [Abstract] [Full text] [PDF]  

Review
Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery

Rajni Sinha, Gloria J. Kim, Shuming Nie, and Dong M. Shin
Mol. Cancer Ther. 2006; 5: 1909-1917. [Abstract] [Full text] [PDF]  

Subject Review
Pharmacogenetics and Regulation of Human Cytochrome P450 1B1: Implications in Hormone-Mediated Tumor Metabolism and a Novel Target for Therapeutic Intervention

Tristan M. Sissung, Douglas K. Price, Alex Sparreboom, and William D. Figg
Mol. Cancer Res. 2006; 4: 135-150. [Abstract] [Full text] [PDF]  

Minireview
Proteasome inhibitor therapy in multiple myeloma

Dharminder Chauhan, Teru Hideshima, Constantine Mitsiades, Paul Richardson, and Kenneth C. Anderson
Mol. Cancer Ther. 2005; 4: 686-692. [Abstract] [Full text] [PDF]  

Review Article
Pharmacology and Pharmacodynamics of Bevacizumab as Monotherapy or in Combination with Cytotoxic Therapy in Preclinical Studies

Hans-Peter Gerber and Napoleone Ferrara
Cancer Res. 2005; 65: 671-680. [Abstract] [Full text] [PDF]  

Perspectives
The Importance of Pharmacokinetic Limited Sampling Models for Childhood Cancer Drug Development

J. Carl Panetta, Lisa C. Iacono, Peter C. Adamson, and Clinton F. Stewart
Clin. Cancer Res. 2003; 9: 5068-5077. [Abstract] [Full text] [PDF]